BIOCEUTICAL PATENT PORTFOLIO FOR LUXEMBOURG BIOCEUTICAL INNOVATIONS
Description
WE HEREBY PUBLISH OUR BIOCEUTICAL PATENT PORTFOLIO THAT MAY PROVIDE EFFICIENT CURATIVE & PREVENTIVE MEANS FOR THE MOST SEEN MEDICAL AILMENTS IN LUXEMBOURG. OUR FORMULATIONS PORTFOLIO LISTED IN THIS DATASET INCLUDES BCL-2 EXPRESSION INHIBITORS, CYCLIN B1 & D2 INHIBITORS, Hıf-10 SUPPRESSIVE AGENTS, TNF-A & NF-KAPPA B COX-2 INTERLEUKIN-6 SUPPRESSIVE AND IMMUNOMODULATIVE AGENTS FOR AUTOIMMUNE DISEASES, FMO3 SUPPRESSIVE ANALGESIC AGENTS, THYROGENIC & THYROMODULATORY AGENTS, RNA POLYMERASE & DNA POLYMERASE & VIRAL DNA GYRASE SUPPRESSIVE ANTIVIRAL AGENTS, TOPOISOMERASE I & II, RIBONUCLEOTIDE REDUCTASE SUPPRESSIVE ANTIBACTERIAL AGENTS, GLUT4 TRANSLOCATIVE ANTIDIABETIC AGENTS AND MANY OTHER INNOVATIVE FORMULATIONS WITH NOVEL MECHANISMS OF ACTION.
WE HEREBY DISCLOSE OUR INVENTIONS FOR THE GREAT PEOPLE OF LUXEMBOURG IN ORDER TO PROVIDE AND EFFICIENT CONTRIBUTION TO THEIR COLLECTIVE HEALTH, AND FOR ALL.
BEST REGARDS
ERDAL CAN ALKOCLAR & METEHAN YESIL
Author
This dataset has been published on the initiative and under the responsibility of
Erdal Can Alkoclar
Published on May 14, 2020 and updated on September 1, 2021
Latest update
May 17, 2020
License
Creative Commons Attribution 4.0
Metadata quality:
Data description filled
Files documented
License filled
Update frequency not followed
File formats are closed
Temporal coverage not set
Spatial coverage not set
All files are available
Metadata quality
Update frequency not followed
File formats are closed
Temporal coverage not set
Spatial coverage not set
There are no reuses for this dataset yet.
There are no discussions for this dataset yet.
There are no community resources for this dataset yet.
Information
Tags
License
ID
5ebcd8a7d2bfb261315f3ca6
Temporality
Creation
May 14, 2020
Frequency
Annual
Latest update
May 17, 2020